Our study demonstrates that ACAA2 expression is elevated in cancers with NE phenotype through assessing the expression profile of ACAA2 in cell lines and xenografts of neuroblastoma as well as cell lines, xenografts, patient mRNA, and patient tissue samples from prostate and lung cancers. This evidence concerns the gene ACAA2 and lung cancer.